CHI3L1 and myeloid sarcoma: The exact role of CHI3L1 requires further elucidation, but it is undeniably expressed within inflammatory events throughout the CNS and thus could be considered a surrogate biomarker that is indicative of MS microglia activity upon neuroinflammation in MS.